Surface modified nsaid nanoparticles
CA 2118517 C · Owner: Nanosystems L.L.C. · Inventors: Liversidge, Gary G.; Conzentino, Philip, Jr.; Cundy, Kenneth C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Dispersible particles consisting essentially of a crystalline NSAID having a surface modifier adsorbed on the surface thereof in an amount sufficient to maintain an effective average particle size of less than about 400 nm. Pharmaceutical compositions containing the particles exhibit reduced gastric irritation following oral administration and/or hastened onset of action.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 1, 1993 and granted October 14, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 1, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 1, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.